why choose us

First received: December 19, 2022

Clinical Trial: Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Understanding the Interaction Between Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Brief Summary: The goal of this research study is to determine whether hormonal therapies used early in the course of prostate cancer could increase the amount of Prostate-Specific Membrane Antigen (PSMA) as detected by PET/CT scans for participants with recurrent prostate cancer.This study will measure PSMA levels using standard PET/CT scans and participants will receive standard-of-care androgen receptor antagonist monotherapy.The names of the treatment interventions involved in this study are:Androgen receptor…

Read more